![Roy F. J. Davis](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Roy F. J. Davis
Direttore Tecnico/Scientifico/R&S presso Immunexpress, Inc.
Profilo
Roy F.
J.
Davis is currently the Chief Medical Officer at Immunexpress, Inc. He obtained a doctorate degree from the Medical College of Virginia.
Posizioni attive di Roy F. J. Davis
Società | Posizione | Inizio |
---|---|---|
Immunexpress, Inc.
![]() Immunexpress, Inc. Miscellaneous Commercial ServicesCommercial Services Immunexpress, Inc. engages in development of revolutionary molecular diagnostics. The firm's SeptiCyte technology quantifies specific and multiple molecular markers from the patient?s own immune system for earlier detection and severity assessment of sepsis, as well as the better timing of drugs and other therapies. The company was founded by Richard Bruce Brandon, Roslyn Brandon and Mervyn Rees Thomas in and is headquartered in | Direttore Tecnico/Scientifico/R&S | 22/10/2015 |
Formazione di Roy F. J. Davis
Medical College of Virginia | Doctorate Degree |
Esperienze
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Relazioni
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
Aziende private | 1 |
---|---|
Immunexpress, Inc.
![]() Immunexpress, Inc. Miscellaneous Commercial ServicesCommercial Services Immunexpress, Inc. engages in development of revolutionary molecular diagnostics. The firm's SeptiCyte technology quantifies specific and multiple molecular markers from the patient?s own immune system for earlier detection and severity assessment of sepsis, as well as the better timing of drugs and other therapies. The company was founded by Richard Bruce Brandon, Roslyn Brandon and Mervyn Rees Thomas in and is headquartered in | Commercial Services |
- Borsa valori
- Insiders
- Roy F. J. Davis